“The award winning pitch by Oncolize clearly explained the unmet needs, the solution and the potential for patients, doctors and investors”.
On the 11th & 12th of December 2017 the 11th European Venture Contest Finals organized by Tech Tours were held in Dusseldorf, Germany.
OncoLize was selected from the previous Benelux session to pitch the business plan and fundraising for the gathered European VC’s, Corporates and family offices.
In the track ‘Biotech’ OncoLize won from 4 other competing companies as ‘Best Biotech Pitch 2017’.
“This business case and well-established technology offers major impact at patient, societal and investor level, using simple, effective solutions based on solid insights in the unmet needs”.
The jury further commented on the disruptive potential of the real-world solutions for the ‘rare and deadly’ tumor diseases such as aggressive braintumors and pancreatic tumors.